Hypertension in the metabolic syndrome and diabetes: pathogenesis, clinical studies, and treatment.
The increasing prevalence of obesity, hypertension, and abnormal glucose metabolism is a major challenge to health care in industrialized societies. This brief review summarizes the mechanistic evidence and clinical studies related to the problem of hypertension in the metabolic syndrome and diabetes to allow clinicians to provide more effective and enlightened management of these common, interrelated problems.
Izzo
Joseph L
JL
Department of Medicine, State University of New York at Buffalo, Buffalo, NY 14209, USA. jizzo@kaleidahealth.org
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology*; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology*; D024821:Metabolic Syndrome / Q000150:complications / Q000503:physiopathology*
D000959:Antihypertensive Agents